Glaxosmithkline | GSK - PE Price to Earnings

Stock Price
52.07
Daily Change
-7.05 -11.92%
Monthly
-14.43%
Yearly
31.66%
Q1 Forecast
52.28

Glaxosmithkline reported 11.93 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Amgen 25.31 15.82 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Aurora Cannabis 23.27 0 Sep/2025
Bausch Health Companies 6.98 0.41 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Corcept Therapeutics 41.9 52.28 Dec/2025
Drreddys Laboratories 18.27 0.84 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Glaxosmithkline 11.93 6.46 Sep/2025
J&J 23.62 0.86 Dec/2025
Merck 13.92 5.08 Dec/2025
Novartis 15.74 0.15 Sep/2025
Pacira 52.68 23.44 Dec/2025
Perrigo 58.96 24.65 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Phibro Animal Health 13.82 4.04 Dec/2025
Prestige Brands 15.31 3.1 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.99 1.58 Dec/2025
Supernus Pharmaceuticals 110.38 71.27 Dec/2025
Takeda 235.05 184.95 Dec/2025
Teva Pharmaceutical Industries 10.11 1.04 Dec/2025
Zoetis 20.42 2.84 Dec/2025